Case Report: Interferon-γ Restores Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) in Severe COVID-19 With Acquired Immunosuppression Syndrome - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Frontiers in Immunology Année : 2021

Case Report: Interferon-γ Restores Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) in Severe COVID-19 With Acquired Immunosuppression Syndrome

Steffen Dickel
  • Fonction : Auteur
  • PersonId : 1100383
Clemens Grimm
  • Fonction : Auteur
Katharina Amschler
  • Fonction : Auteur
Sebastian Uwe Schnitzler
  • Fonction : Auteur
Julie Schanz
  • Fonction : Auteur
Onnen Moerer
  • Fonction : Auteur
Bjoern Tampe
  • Fonction : Auteur
Martin Sebastian Winkler
  • Fonction : Auteur

Résumé

Background The major histocompatibility complex (MHC) class II characterized by monocytes CD14+ expression of human leukocyte antigen receptors (HLA-DR), is essential for the synapse between innate and adaptive immune response in infectious disease. Its reduced expression is associated with a high risk of secondary infections in septic patients and can be safely corrected by Interferon-y (IFNy) injection. Coronavirus disease (COVID-19) induces an alteration of Interferon (IFN) genes expression potentially responsible for the observed low HLA-DR expression in circulating monocytes (mHLA-DR). Methods We report a case of one-time INFy injection (100 mcg s.c.) in a superinfected 61-year-old man with COVID-19–associated acute respiratory distress syndrome (ARDS), with monitoring of mHLA-DR expression and clinical tolerance. Observations Low mHLA-DR pretreatment expression (26.7%) was observed. IFNy therapy leading to a rapid increase in mHLA-DR expression (83.1%). Conclusions Severe ARDS in a COVID-19 patient has a deep reduction in mHLA-DR expression concomitantly with secondary infections. The unique IFNy injection was safe and led to a sharp increase in the expression of mHLA-DR. Based on immune and infection monitoring, more cases of severe COVID-19 patients with low mHLA-DR should be treated by IFNy to test the clinical effectiveness.
Fichier principal
Vignette du fichier
fimmu-12-645124.pdf (495.52 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03243515 , version 1 (31-05-2021)

Licence

Paternité

Identifiants

Citer

Steffen Dickel, Clemens Grimm, Katharina Amschler, Sebastian Uwe Schnitzler, Julie Schanz, et al.. Case Report: Interferon-γ Restores Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) in Severe COVID-19 With Acquired Immunosuppression Syndrome. Frontiers in Immunology, 2021, 12, pp.645124. ⟨10.3389/fimmu.2021.645124⟩. ⟨hal-03243515⟩

Collections

UP-SANTE
93 Consultations
67 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More